World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
40092
World Ranking
7939
National Ranking
459

Overview

Wilko Weichert is affiliated with the Technical University of Munich in Germany. Their academic focus spans multiple fields within the biomedical sciences, with a primary emphasis on Medicine and Biochemistry, Genetics and Molecular Biology. This interdisciplinary approach supports research across various subfields including Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, and Surgery.

Their research topics cover a range of significant areas. These include Cancer Genomics and Diagnostics, Pancreatic and Hepatic Oncology Research, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Genetic factors in colorectal cancer, Radiomics and Machine Learning in Medical Imaging, as well as Epigenetics and DNA Methylation.

Wilko Weichert has contributed to numerous publications, with frequent appearances in the following venues:

  • Cancers
  • Annals of Oncology
  • Laryngo-Rhino-Otologie
  • bioRxiv (Cold Spring Harbor Laboratory)
  • British Journal of Cancer

Their recent published papers include the following:

  • Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers, 2021, Cancer Discovery
  • Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer, 2023, Nature Medicine
  • Single-Nucleus and In Situ RNA-Sequencing Reveal Cell Topographies in the Human Pancreas, 2020, Gastroenterology
  • Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance, 2022, Clinical Cancer Research
  • Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix, 2020, Journal of Clinical Investigation

Weichert often collaborates with other researchers, with frequent co-authors including Katja Steiger, Nicole Pfarr, Albrecht Stenzinger, Moritz Jesinghaus, and Peter Schirmacher. These collaborations indicate involvement in diverse research projects and extensive scientific networking.

Best Publications

  • Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

    Carsten Denkert;Sibylle Loibl;Aurelia Noske;Marc Roller

  • Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

    Irène Baccelli;Andreas Schneeweiss;Sabine Riethdorf;Albrecht Stenzinger

  • The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

    Ali Afshar-Oromieh;Eleni Avtzi;Frederik L. Giesel;Tim Holland-Letz

  • The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival

    Arne Warth;Thomas Muley;Michael Meister;Albrecht Stenzinger

  • Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

    W Weichert;A Röske;V Gekeler;T Beckers

  • Fungi and inflammatory bowel diseases: Alterations of composition and diversity

    Stephan J Ott;Tanja Kühbacher;Meike Musfeldt;Philip Rosenstiel

  • Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.

    Carsten Denkert;Jan Budczies;Tobias Kind;Wilko Weichert

  • HDAC expression and clinical prognosis in human malignancies

    Wilko Weichert

  • Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo

    Wilko Weichert;Annika Röske;Silvia Niesporek;Aurelia Noske

  • Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis

    Wilko Weichert;Annika Röske;Volker Gekeler;Thomas Beckers

  • Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.

    Joachim Weischenfeldt;Joachim Weischenfeldt;Taronish Dubash;Alexandros P Drainas;Balca R Mardin

  • Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding.

    Clemens Kratochwil;Frank Bruchertseifer;Hendrik Rathke;Marcus Bronzel

  • Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover.

    Carsten Denkert;Jan Budczies;Wilko Weichert;Gert Wohlgemuth

  • Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes

    Sebastian Mueller;Thomas Engleitner;Thomas Engleitner;Roman Maresch;Roman Maresch;Magdalena Zukowska

  • Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas

    Andreas H Scheel;Manfred Dietel;Lukas C Heukamp;Korinna Jöhrens

  • Distinct types of tumor-initiating cells form human colon cancer tumors and metastases

    Sebastian M. Dieter;Claudia R. Ball;Christopher M. Hoffmann;Ali Nowrouzi

  • ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival.

    W Weichert;T Knösel;J Bellach;M Dietel

  • Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.

    Carsten Denkert;Klaus-Jürgen Winzer;Berit-Maria Müller;Wilko Weichert

  • CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy

    Christine E Engeland;Christine E Engeland;Christian Grossardt;Rūta Veinalde;Sascha Bossow

  • Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.

    Aurelia Noske;Wilko Weichert;Silvia Niesporek;Annika Röske

Frequent Co-Authors

Albrecht Stenzinger
Albrecht Stenzinger Heidelberg University
Carsten Denkert
Carsten Denkert Philipp University of Marburg
Manfred Dietel
Manfred Dietel Charité - University Medicine Berlin
Peter Schirmacher
Peter Schirmacher University Hospital Heidelberg
Roland Penzel
Roland Penzel University Hospital Heidelberg
Hanno Glimm
Hanno Glimm TU Dresden
Roland Eils
Roland Eils Charité - University Medicine Berlin
Benedikt Brors
Benedikt Brors German Cancer Research Center
Roland Rad
Roland Rad Technical University of Munich
Peter Neuhaus
Peter Neuhaus Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine but want flexible options, several online degrees and alternative pathways can help you get started in healthcare. For registered nurses seeking advancement, finding the cheapest rn to bsn program online can be a cost-effective way to earn a Bachelor’s degree while working.

Non-nurses looking to transition quickly into advanced nursing roles might consider direct entry msn programs for non-nurses online, which allow graduates from other fields to get into nursing leadership or specialist roles faster. Similarly, online bsn programs for non nurses offer a path into the nursing profession without having previous nursing credentials.

Not everyone drawn to healthcare wants to be a clinician. For those interested in the administrative or technical side, there are medical billing and coding schools with financial aid that prepare students for in-demand roles supporting hospitals and clinics. With these flexible learning pathways, entering the healthcare field is more accessible than ever.

Best Scientists Citing Wilko Weichert

Trending Scientists